
A rare variant of a protein found in human cells may hold the key to transforming breast cancer treatment, scientists have said.
Experts believe that targeting this variant – called RAC1B – may “dramatically boost” treatment effectiveness.

A rare variant of a protein found in human cells may hold the key to transforming breast cancer treatment, scientists have said.
Experts believe that targeting this variant – called RAC1B – may “dramatically boost” treatment effectiveness.